CN109642888B - Polar fluid gated field effect device - Google Patents
Polar fluid gated field effect device Download PDFInfo
- Publication number
- CN109642888B CN109642888B CN201780050922.5A CN201780050922A CN109642888B CN 109642888 B CN109642888 B CN 109642888B CN 201780050922 A CN201780050922 A CN 201780050922A CN 109642888 B CN109642888 B CN 109642888B
- Authority
- CN
- China
- Prior art keywords
- field effect
- effect transistor
- polar fluid
- glucose
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 114
- 230000005669 field effect Effects 0.000 title claims abstract description 64
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 96
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 85
- 238000000034 method Methods 0.000 claims abstract description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 106
- 239000008103 glucose Substances 0.000 claims description 78
- 210000004243 sweat Anatomy 0.000 claims description 62
- 229920000642 polymer Polymers 0.000 claims description 37
- 239000002086 nanomaterial Substances 0.000 claims description 31
- 239000000758 substrate Substances 0.000 claims description 30
- 229910052751 metal Inorganic materials 0.000 claims description 28
- 239000002184 metal Substances 0.000 claims description 28
- 239000012491 analyte Substances 0.000 claims description 25
- MWEKPLLMFXIZOC-UHFFFAOYSA-N pyren-1-ylboronic acid Chemical compound C1=C2C(B(O)O)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 MWEKPLLMFXIZOC-UHFFFAOYSA-N 0.000 claims description 24
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 23
- 108020003175 receptors Proteins 0.000 claims description 17
- 102000005962 receptors Human genes 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 9
- 102000053602 DNA Human genes 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 108091023037 Aptamer Proteins 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 239000000976 ink Substances 0.000 claims description 7
- -1 phosphorus alkene Chemical class 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 6
- 239000004642 Polyimide Substances 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 5
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 5
- 229920001721 polyimide Polymers 0.000 claims description 5
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 5
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 229910003472 fullerene Inorganic materials 0.000 claims description 4
- 230000006870 function Effects 0.000 claims description 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 4
- 229910010272 inorganic material Inorganic materials 0.000 claims description 4
- 239000011147 inorganic material Substances 0.000 claims description 4
- 239000004753 textile Substances 0.000 claims description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 3
- QHAXDWSSXNJXCP-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione pyrene Chemical compound ON1C(=O)CCC1=O.c1cc2ccc3cccc4ccc(c1)c2c34 QHAXDWSSXNJXCP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052582 BN Inorganic materials 0.000 claims description 3
- 102000004127 Cytokines Human genes 0.000 claims description 3
- 108090000695 Cytokines Proteins 0.000 claims description 3
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 3
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 3
- 102000004889 Interleukin-6 Human genes 0.000 claims description 3
- 108090001005 Interleukin-6 Proteins 0.000 claims description 3
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000013060 biological fluid Substances 0.000 claims description 3
- 229920001222 biopolymer Polymers 0.000 claims description 3
- 210000002939 cerumen Anatomy 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229960000890 hydrocortisone Drugs 0.000 claims description 3
- 239000002207 metabolite Substances 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 claims description 2
- 229910001218 Gallium arsenide Inorganic materials 0.000 claims description 2
- 229910000927 Ge alloy Inorganic materials 0.000 claims description 2
- GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 229910000676 Si alloy Inorganic materials 0.000 claims description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 230000008827 biological function Effects 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 229910052732 germanium Inorganic materials 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 2
- 229910052594 sapphire Inorganic materials 0.000 claims description 2
- 239000010980 sapphire Substances 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000370 acceptor Substances 0.000 claims 1
- 238000000469 dry deposition Methods 0.000 claims 1
- 239000012777 electrically insulating material Substances 0.000 claims 1
- UGFMBZYKVQSQFX-UHFFFAOYSA-N para-methoxy-n-methylamphetamine Chemical compound CNC(C)CC1=CC=C(OC)C=C1 UGFMBZYKVQSQFX-UHFFFAOYSA-N 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 230000001052 transient effect Effects 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 117
- 230000004044 response Effects 0.000 description 85
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 60
- 239000011780 sodium chloride Substances 0.000 description 56
- 239000010410 layer Substances 0.000 description 55
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 48
- 239000008280 blood Substances 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 26
- 235000014655 lactic acid Nutrition 0.000 description 24
- 239000004310 lactic acid Substances 0.000 description 24
- 230000035945 sensitivity Effects 0.000 description 24
- 238000005259 measurement Methods 0.000 description 23
- 230000001965 increasing effect Effects 0.000 description 18
- 230000008859 change Effects 0.000 description 16
- 238000007306 functionalization reaction Methods 0.000 description 16
- 230000037081 physical activity Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000002131 composite material Substances 0.000 description 11
- 125000005647 linker group Chemical group 0.000 description 11
- 238000012544 monitoring process Methods 0.000 description 11
- 150000002500 ions Chemical class 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000001747 exhibiting effect Effects 0.000 description 5
- 229920005570 flexible polymer Polymers 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 210000000106 sweat gland Anatomy 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 229910002804 graphite Inorganic materials 0.000 description 3
- 239000010439 graphite Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920000307 polymer substrate Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 3
- 229910010271 silicon carbide Inorganic materials 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- JHYNEQNPKGIOQF-UHFFFAOYSA-N 3,4-dihydro-2h-phosphole Chemical compound C1CC=PC1 JHYNEQNPKGIOQF-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- DBDNZCBRIPTLJF-UHFFFAOYSA-N boron(1-) monohydride Chemical compound [BH-] DBDNZCBRIPTLJF-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002800 charge carrier Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011898 label-free detection Methods 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010963 scalable process Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
- G01N15/0656—Investigating concentration of particle suspensions using electric, e.g. electrostatic methods or magnetic methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
- G01N27/4145—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS specially adapted for biomolecules, e.g. gate electrode with immobilised receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
- G01N27/4146—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS involving nanosized elements, e.g. nanotubes, nanowires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Thin Film Transistor (AREA)
Abstract
Nanoscale Field Effect Transistors (NFETs), such as graphene-based field effect transistors (GFETs), that do not have a physical gate are disclosed herein. Instead, they are gated by polar fluids. Systems and methods of using such transistors are also disclosed.
Description
Cross Reference to Related Applications
The present application claims priority from U.S. provisional patent application No. 62/356,729 entitled DETECTION ionization correlation IN fluorescent use, nanoscale domains VIA A CAPACITIVE RESPONSE, filed on 30.6.2016 and U.S. provisional patent application No. 62/356,742 entitled "DETECTION-ionization correlation domains FOR molecular DETECTION domains FOR LABEL-FREE DETECTION OF LACTATE INSWEAT AND organic crystal directions", filed on 30.6.2016, each OF which is incorporated herein by reference IN its entirety.
Technical Field
The invention disclosed herein relates generally to the design, fabrication, and application of polar fluid (polar fluid) gated Nanoscale Field Effect Transistors (NFETs), particularly Graphene Field Effect Transistors (GFETs). The present disclosure also relates generally to chemical and biological sensing using field effect transistors, and more particularly to biochemical sensing using field effect transistors with biochemically sensitive channels involving graphene.
Background
A Field Effect Transistor (FET) is a transistor that uses an electric field to control the electrical behavior of a device. Typically, a FET has three terminals (e.g., source, drain, and gate) and an active channel. Charge carriers (electrons or holes) flow from the source to the drain through an active channel, for example formed of a semiconductor material.
The source (S) is where the carriers enter the channel. The drain (D) is where the carriers leave the channel. The drain-source voltage is VDS and the source-drain current is IDS. The gate (G) modulates the channel conductivity by applying a gate Voltage (VG) to control the current between the source and drain.
Nanoscale Field Effect Transistors (NFETs), such as Graphene Field Effect Transistors (GFETs), are widely used in many applications, such as bioprobes, implants, and the like.
What is needed in the art are better FET designs and new methods of using them.
Disclosure of Invention
In one aspect, a field effect transistor is disclosed herein. The field effect transistor includes: a drain electrode; a drain electrode; a source electrode; an electrically insulating substrate; a nanoscale material layer disposed on the substrate, the nanoscale material layer partially defining an electrically conductive and chemically sensitive channel, the nanoscale material layer and channel extending between and electrically connected to the drain electrode and the source electrode; the gate terminal induced by the polarized fluid is created by the polar fluid exposed to the nanoscale material layer. In some embodiments, the polar fluid comprises a target analyte. In further embodiments, the polar fluid has a charge concentration sufficient to induce a polar fluid gate voltage that optimizes the gate voltage according to channel current characteristics of the (vers) field effect transistor in response to the target analyte.
In some embodiments, a constant current provided by a constant current source or a constant voltage provided by a constant voltage source is applied between the source electrode and the drain electrode.
In some embodiments, the nanoscale material comprises graphene, CNT, moS2Boron nitride, a metal disulfide, a phospholene, a nanoparticle, a quantum dot, a fullerene, a 2D nanoscale material, a 3D nanoscale material, a 0D nanoscale material, a 1D nanoscale material, or any combination thereof.
In some embodiments, wherein the polar fluid comprises a solution having polar molecules, a gas having polar molecules, a target sensing analyte, or a combination thereof.
In some embodiments, the polar fluid comprises sweat, breath, saliva, cerumen, urine, semen, plasma, biological fluid, chemical fluid, air sample, gas sample, or combinations thereof
In some embodiments, the target analyte comprises an electrolyte, glucose, lactate, IL6, cytokine, HER2, cortisol, ZAG, cholesterol, vitamin, protein, drug molecule, metabolite, polypeptide, amino acid, DNA, RNA, aptamer, enzyme, biomolecule, chemical molecule, synthetic molecule, or a combination thereof.
In some embodiments, the field effect transistor further comprises: a receptor layer deposited on the nanoscale material layer, wherein the receptor layer comprises a receptor targeted to a target analyte.
In some embodiments, the receptor comprises pyreneboronic acid (PBA), pyrene N-hydroxysuccinimide ester (pyrene-NHS), organic chemicals, aromatic molecules, cyclic molecules, enzymes, proteins, antibodies, viruses, single stranded DNA (ssDNA), aptamers, inorganic materials, synthetic molecules, biomolecules.
In some embodiments, the field effect transistor further comprises: a back polymer layer underlying the nanoscale material layer to provide support for additional mechanical, electrical, chemical, biological functionality, or a combination thereof.
In some embodiments, the back polymer layer comprises: carbon polymers, biopolymers, PMMA, PDMS, flexible glass, nanoscale materials, silica gel, silicones, inks, printed polymers, or any combination thereof.
In one aspect, a method for sensing a target analyte in a polar fluid is disclosed herein. The method comprises the following steps: exposing the polar fluid sample to a field effect transistor, wherein the field effect transistor comprises: a drain electrode; a source electrode; an electrically insulating substrate; a nanoscale material layer disposed on the substrate, the nanoscale material layer at least partially defining an electrically conductive and chemically sensitive channel, the nanoscale material layer and channel extending between and electrically connected to the drain electrode and the source electrode; a polar fluid induced gate terminal resulting from exposure of a polar fluid to the nanoscale material layer, wherein the polar fluid includes a target analyte and has a charge concentration sufficient to induce a polar fluid gate voltage that optimizes the gate voltage according to channel current characteristics of the field effect transistor for detection of the analyte; measuring a first source-drain voltage at a first point in time and a second source-drain voltage at a second and subsequent point in time; based on the first and second source-drain voltages, a concentration of a target analyte in the polar fluid is determined.
In some embodiments, the nanoscale materials comprise graphene, CNT, moS2Boron nitride, a metal disulfide, a phospholene, a nanoparticle, a quantum dot, a fullerene, a 2D nanoscale material, a 3D nanoscale material, a 0D nanoscale material, a 1D nanoscale material, or any combination thereof.
In some embodiments, the field effect transistor is functionalized with a receptor layer deposited on the nanoscale material layer, and wherein the receptor layer comprises a receptor targeted to a target analyte.
In some embodiments, the receptor comprises pyreneboronic acid (PBA), pyrene N-hydroxysuccinimide ester (pyrene-NHS), organic chemicals, aromatic molecules, cyclic molecules, enzymes, proteins, antibodies, viruses, single stranded DNA (ssDNA), aptamers, inorganic materials, synthetic molecules, biomolecules.
In some embodiments, the target analyte comprises an electrolyte, glucose, lactate, IL6, cytokine, HER2, cortisol, ZAG, cholesterol, vitamin, protein, drug molecule, metabolite, polypeptide, amino acid, DNA, RNA, aptamer, enzyme, biomolecule, chemical molecule, synthetic molecule, or a combination thereof.
In some embodiments, the polar fluid comprises a solution having polar molecules, a gas having polar molecules, a target sensing analyte, or a combination thereof.
In some embodiments, the method further comprises calculating a small change between the first source-drain voltage and the second source-drain voltage.
In some embodiments, the method further comprises: a constant current is applied between the source electrode and the drain electrode of the field effect transistor.
In some embodiments, the method further comprises: a constant voltage is applied between the source and drain electrodes of the field effect transistor.
In some embodiments, the polar fluid comprises sweat, breath, saliva, cerumen, urine, semen, plasma, biological fluid, chemical fluid, air sample, gas sample, or combinations thereof
In some embodiments, the method further comprises: a back polymer layer underlying the nanoscale material layer to provide support for additional mechanical, electrical, chemical, biological functions, or a combination thereof.
In some embodiments, the back polymer layer comprises: carbon polymers, biopolymers, PMMA, PDMS, flexible glass, nanoscale materials, silica gel, silicones, inks, printed polymers, or any combination thereof.
In one aspect, disclosed herein is a system comprising: a field effect transistor; and
a constant current source or a constant voltage source electrically connected to the field effect transistor. The field effect transistor includes: a drain electrode; a source electrode; an electrically insulating substrate; a nanoscale material layer disposed on the substrate, the nanoscale material layer partially defining an electrically conductive and chemically sensitive channel, the nanoscale material layer and channel extending between and electrically connected to the drain electrode and the source electrode; the polarized fluid induced gate terminal is created by the polar fluid exposed to the nanoscale material layer. In some embodiments, the polar fluid comprises a target analyte. In some embodiments, the polar fluid has a charge concentration sufficient to induce a polar fluid gate voltage that optimizes the gate voltage according to channel current characteristics of the field effect transistor in response to the target analyte.
In some embodiments, the constant current source maintains a constant current through the field effect transistor.
In some embodiments, the constant voltage source maintains a constant voltage across the field effect transistor.
In some embodiments, the voltage output or the current output is transmitted to the digital platform by wired or wireless transmission.
In some implementations, the digital platform includes a smartphone, a tablet computer, a smart watch, an in-vehicle entertainment system, a notebook computer, a desktop computer, a computer terminal, a television system, an e-book reader, a wearable device, or any other type of computing device that processes digital input.
Any of the embodiments disclosed herein may be used in conjunction with any aspect of the present invention, alone or in combination with other embodiments, as known to those skilled in the art.
Drawings
Those skilled in the art will appreciate that the drawings described below are for illustration purposes only. The drawings are not intended to limit the scope of the present teachings in any way.
Fig. 1A depicts a prior art embodiment, showing a graphene field effect transistor (gFET).
FIG. 1B depicts a prior art embodiment, showing current flow between source and drain controlled by gate voltage.
Fig. 2A depicts an exemplary embodiment, demonstrating a gate-less graphene field effect (g-gFET).
FIG. 2B depicts an exemplary embodiment, demonstrating a g-gFET.
FIG. 2C depicts an exemplary embodiment, illustrating a g-gFET.
FIG. 2D depicts an exemplary embodiment, illustrating a g-gFET.
Fig. 3A depicts an exemplary embodiment, illustrating a Polar Fluid Gate Terminal (PFGT), wherein the polar fluid has no movement.
Fig. 3B depicts an exemplary embodiment, showing a polar fluid gate terminal, wherein the polar fluid flows in a first direction.
Fig. 3C depicts an exemplary embodiment, showing a polar fluid gate terminal, wherein the polar fluid flows in a second direction.
Fig. 4A depicts an exemplary embodiment showing a base device with a dielectric and a gate metal as shown in fig. 2A-2D. The gate potential is measured between the gate metal and ground.
Fig. 4B depicts an exemplary embodiment showing a base device with an added metal electrode in the PFGT as shown in fig. 2A-2D. The gate potential is measured between the metal electrode and ground.
Fig. 4C depicts an exemplary embodiment showing the basic device enhanced with dielectric and gate metal and metal electrodes in the PFGT as shown in fig. 2A-2D. Two gate potentials are measured as shown.
Fig. 5A depicts an exemplary embodiment showing a GFET used in conjunction with a constant current source.
Fig. 5B depicts an exemplary embodiment, illustrating a GFET used in conjunction with a constant voltage source.
Fig. 6 shows an exemplary embodiment demonstrating selective measurement of NaCl response in DI (deionized) water.
Fig. 7 shows an exemplary embodiment demonstrating sensitivity measurement of NaCl response in DI water.
Fig. 8 shows an exemplary embodiment demonstrating chloride response in sweat.
Fig. 9 illustrates an exemplary embodiment demonstrating selective measurement of glucose response in DI water.
Fig. 10 shows an exemplary embodiment demonstrating the glucose response in NaCl versus the glucose response in DI water.
FIG. 11 shows an exemplary embodiment demonstrating selective measurement of glucose response in NaCl water.
Fig. 12 illustrates an exemplary embodiment demonstrating the sensitivity measurement of the D-glucose response in DI water.
Fig. 13 illustrates an exemplary embodiment, demonstrating the functionalized step of making visualization through a GFET.
FIG. 14 shows an exemplary embodiment demonstrating the D-glucose response in sweat.
FIG. 15 shows an exemplary embodiment demonstrating the D-glucose response in blood.
Fig. 16 illustrates an exemplary embodiment demonstrating the measurement correlation between blood glucose and sweat glucose.
Fig. 17 shows an exemplary embodiment demonstrating selective measurement of lactate response in DI water.
Fig. 18 shows an exemplary embodiment demonstrating selective measurement of lactate response in various solutions.
Fig. 19 shows an exemplary embodiment demonstrating the response of lactic acid in NaCl versus that in DI water.
Fig. 20 shows an exemplary embodiment illustrating the lactic acid functionalization step visualized by GFET manufacturing.
Fig. 21 shows an exemplary embodiment, demonstrating a model of sensor correlation with sweat sodium concentration.
Fig. 22 shows an exemplary embodiment, demonstrating a model of the correlation of a sensor to sweat glucose concentration.
Fig. 23 shows an exemplary embodiment, illustrating the transconductance curve of a PFT.
Detailed Description
Nanoscale field effect transistors and methods of making and using the same are disclosed herein.
Overview of graphene field-Effect transistors
Graphene has significant mechanical resistance; this allows the thickness of the monolayer or bilayer to withstand significant mechanical stress without losing its primary electrical properties. This mechanical strength makes graphene an ideal candidate to replace the current Transparent Conducting Oxide (TCO) guided by Indium Tin Oxide (ITO). Unlike graphene, ITO is brittle and susceptible to mechanical stress; however, its low sheet resistance and high transparency are sufficient to offset its high material costs. On the other hand, the production of large area and low sheet resistance graphene sheets is a relatively simple and scalable process using Chemical Vapor Deposition (CVD), which, after proper processing, yields atomic layers with little transparency above 90% and sheet resistance below 100%.
As shown in FIG. 1A, graphene FETs are typically covered with SiO2The Si wafer of the layer is fabricated and the graphene forms the transistor channel. The graphene transistor consists of three terminals: source and drain metal electrodes in contact with the graphene channel and a global back gate realized by a doped Si substrate. These features contribute to the characteristic bipolar transport behavior of graphene in a Grat-FET, achieving both n-type and p-type transport when biased at an appropriate gate voltage on the substrate. Any suitable method may be employed to manufacture a GFET, including, for example, the information disclosed in international patent publication No. WO 2015/164,552, which is incorporated by reference herein in its entirety.
Fig. 1B shows the current between source and drain controlled by the gate voltage. By changing the direction and magnitude of the gate voltage, the resulting curve of current flow through the source and drain is "V" shaped. At the tip of the V-shaped curve, a small change in gate voltage results in a channel current (I)DS) And tends to be smooth at both ends of the V-shaped curve.
Non-grid field effect transistor
In one aspect, disclosed herein is a novel Field Effect Transistor (FET) without a physical gate.
Fig. 2A-2D depict various embodiments of FETs without physical gates. Fig. 2A depicts an exemplary graphene-based FET 210, which includes a substrate 1, a source electrode 2, a drain electrode 3, a receptor 4, a graphene layer 5, and a back polymer 6. As disclosed herein, the substrate 1 may be polyamide, PET, PDMS, PMMA, other plastics, silica, silicon, glass, alumina, sapphire, germanium, gallium arsenide, indium phosphide, alloys of silicon and germanium, fabric, textile, wire, paper, cellulose backing material, insulators, metals, semiconductors, may be rigid, flexible, or any combination thereof. In some embodiments, the substrate 1 may be a silicon carbide substrate, and the graphene layer 5 may be epitaxially grown on the silicon carbide substrate directly by sublimation of silicon from the silicon carbide substrate (fig. 2B).
The source electrode 2 is an electrode region in a field effect transistor, and majority carriers flow from the electrode region into an inter-electrode conduction path. Exemplary materials that can be used as the source electrode include, but are not limited to, silver, gold, carbon, graphite ink, conductive fabric, conductive textile, metal, conductive material, conductive polymer, conductive gel, ionic gel, conductive ink, non-metallic conductive material.
The drain electrode 3 is an electrode on the opposite side to the source electrode 2. Exemplary materials that can be used as the source electrode include, but are not limited to, silver, gold, carbon, graphite ink, conductive fabric, conductive textile, metal, conductive material, conductive polymer, conductive gel, ionic gel, conductive ink, non-metallic conductive material.
In some embodiments, the graphene layer 5 may have one or more graphene monolayers of uniform thickness, preferably of predetermined thickness. Since the thickness affects electrical characteristics, such as band gap, carrier concentration, etc., a uniform and preferably predetermined thickness provides control of the sensing characteristics and enables the formation of reproducible devices with low variability between individual sensors.
In some embodiments, the graphene layer 5 may be an epitaxial layer, and the graphene layer substrate may be a substrate on which the graphene layer is epitaxially grown. By leaving the graphene layer on the substrate on which it is grown, it is generally not necessary to process the nanoscale graphene layer and structure. Furthermore, when the graphene layer may remain on the substrate, the risk of damaging the thin graphene layer during the manufacture of the transistor is also reduced.
In some embodiments, the graphene layer 5 may be surface treated with the receptor 4 to obtain selectivity such that only selected types of analytes are detected by the graphene layer. Exemplary receptors 4 include, but are not limited to, pyreneboronic acid (PBA), N-hydroxysuccinimide ester (pyrene-NHS), organic chemicals, aromatic molecules, cyclic molecules, enzymes, proteins, antibodies, viruses, single stranded DNA (ssDNA), aptamers, inorganic materials, synthetic molecules, biomolecules.
In some embodiments, the graphene layer 5 and/or certain types of chemical species are prevented from reaching the chemically sensitive channels. The surface treatment may include deposition of metal particles and/or polymers.
The back polymer 6 is used to provide mechanical support for the graphene. And when doped, a new mode can be added for the sensing response. For example, the post-polymer may be doped with biomolecules that may also bind to a specific target and contribute to the resistance change of the transistor channel.
As disclosed herein, a device or base device may be any of devices 210, 220, 230, and 240.
Polar Fluid Gate Terminal (PFGT)
Graphene is an allotrope of carbon in the form of a hexagonal lattice at two-dimensional atomic scale, with one atom forming each vertex. Graphene is the basic structural element of other allotropes, including graphite, charcoal, carbon nanotubes, and fullerenes. Graphene can be considered as an infinite aromatic molecule, the limiting case of flat polycyclic aromatics. In some embodiments, the graphene is a monolayer of carbon atoms. Each carbon atom in graphene has four electrons. With three of these electrons, the carbon atom combines with three nearest neighbors to form a hexagonal lattice. For each atom, the fourth electron is delocalized across the entire graphene layer, which allows conduction of an electron current.
When a polar fluid is deposited on a graphene layer, the particular electronic properties of the graphene will cause the charges in the polar fluid to reorganize and form a liquid induced gate voltage that can modulate the current between the source and drain electrodes.
Fig. 3A depicts an exemplary embodiment showing a polar fluid gate terminal in which the polar fluid has no motion. As shown, the charge of the polar or ionic component is redistributed in the polar fluid to produce a Polar Fluid Gate Terminal (PFGT) and an induced fluid gate Voltage (VGT)FG). This voltage can cause a shift in the V-shaped current from the x-axis (voltage) in the fluid gate voltage curve. As described above, at the tip of the V-shaped curve, a small change in gate voltage may result in a channel current (I)DS) And tends to be smooth at both ends of the V-shaped curve. A shift towards the tip of the V-shaped curve may result in enhanced sensitivity: very small voltage changes in response to current changes can be detected. Similarly, very small current changes in response to voltage changes may also be detected.
As mentioned above, a shift towards the tip of the V-shaped curve may result in better sensitivity. This offset may be caused by the gate voltage induced by the polar liquid. In some embodiments, the gate voltage induced by the polar liquid is related to the concentration of charged particles within the polar fluid. In some embodiments, the concentration may reflect the total amount of all negatively charged particles or all positively charged particles. The variation of the V-shaped curve can be associated with a wide range of charged particle concentrations. In some embodiments, the offset is associated with a charged particle concentration as low as 1 femtogram/liter (e.g., naCl). In some embodiments, the offset is associated with a charged particle concentration of up to 300 grams/liter (e.g., naCl). The results show that the current sensing system is flexible and can withstand a wide range of charge concentrations.
Fig. 3B depicts an exemplary embodiment, showing a polar fluid gate terminal, wherein the polar fluid flows in a first direction. Gate potential (V)FG) Will be proportional to the flow rate of the polar fluid. VFGDepending on the direction of flow of the polar fluid; for exampleAlong and through the source drain terminals. For example, if the gate voltage is positive in the source-drain direction, it is negative in the reverse direction, and vice versa. When a polar fluid flows through the source-drain voltage, if the gate voltage is positive in the Y-direction, it is negative in the-Y-direction, and vice versa. When the direction of the polar fluid flow changes, the direction of the gate voltage will also change.
Fig. 3C depicts an exemplary embodiment showing a polar fluid gate terminal in which the polar fluid flows in a second direction opposite the first direction.
Detecting gate voltage of polar fluid gate terminal
Fig. 4A to 4C show arrangements by which the gate voltage at the Polar Fluid Gate Terminal (PFGT) is determined.
Fig. 4A depicts an exemplary embodiment showing a base device with a dielectric layer 7 and a gate metal 8. Here, the base device may be any of the devices depicted in fig. 2A-2D, such as 210, 220, 230, and 240. The gate potential is measured between the gate metal and ground. A dielectric layer 7 is added below the substrate of the base device (e.g., substrate 1 as shown in fig. 2A-2D). A gate metal 8 is added under the dielectric layer 7. The gate metal 8 is added only to measure the induced gate voltage and no voltage is applied through the gate metal 8. In some embodiments, vg1 may vary in a non-linear manner depending on PFGT device characteristics and channel type. For example, if the channel is graphene (bipolar), vg1 may follow the transconductance response typical of graphene devices.
Fig. 4B depicts an exemplary embodiment showing the basic device as shown in fig. 2A-2D with an added metal electrode in the PFGT. The gate potential is measured between the metal electrode and ground. Vg2 is the top gate voltage formed by the double layer capacitance between the added metal electrode and the active channel. Vg2 may vary in a non-linear manner depending on the PFGT device characteristics and channel type. For example, if the channel is graphene (bipolar), vg2 will follow the typical transconductance response of graphene devices (see, e.g., fig. 23).
Fig. 4C depicts an exemplary embodiment showing the basic device as shown in fig. 2A-2D enhanced with dielectric and gate metal, and metal electrodes in the PFGT. Two gate potentials are measured as shown. The two gate potentials (Vg 1 and Vg 2) are the electrical output that is regulated using source-drain current/voltage and inductive PFG. The simultaneous measurement of Vg1 and Vg2 creates a triple-gated structure that can be used to develop next generation microprocessors, logic gates, computational circuits, radio Frequency (RF) devices, sensors, and the like.
Fig. 4C depicts an exemplary embodiment showing the basic device as shown in fig. 2A-2D enhanced with dielectric and gate metal, and metal electrodes in the PFGT. Two gate voltages (e.g., vg1 and Vg 2) are provided to the PFGT to adjust the overall electrical characteristics of the PFGT device for the desired application. The simultaneous modulation of Vg1 and Vg2 results in a triple-gated structure that can be used to convert device operation to desired electrical performance in a more controlled manner using minimal energy. Such devices may be used in the development of next generation microprocessors, logic gates, computing circuits, radio Frequency (RF) devices, sensors, and the like.
Fig. 5A depicts an exemplary embodiment, demonstrating a circuit for sensor readout via a Polar Fluid Graphene Field Effect Transistor (PFGFET). In FIG. 5A, the constant current (I)C) Is provided to the PFGFET. Reading an output voltage (V) from across a PFGFET using a voltage divider and a current limiting resistor (R)OUT). The voltage output is then calibrated to the concentration of the analyte being sensed.
Fig. 5B depicts an exemplary embodiment showing another circuit for sensor readout via a PFGFET. Here, constant voltage (V)S) Is provided to the PFGFET. Reading current or charge (I) from PFGFET using a current limiting resistor (R)OUT). The current output is then calibrated to the concentration of the analyte being sensed.
Having described the invention in detail, it will be readily understood that modifications, variations, and equivalents may be made thereto without departing from the scope of the invention defined in the appended claims. Furthermore, it should be understood that all examples in the present invention are provided as non-limiting examples.
Examples
The following non-limiting examples are provided to further illustrate the embodiments of the invention disclosed herein. It should be appreciated by those of skill in the art that the techniques disclosed in the embodiments that follow represent methodologies that have been found to function well in the practice of the invention, and thus can be considered to constitute examples of modes for its practice. However, those of skill in the art should, in light of the present disclosure, appreciate that many changes can be made in the specific embodiments which are disclosed and still obtain a like or similar result without departing from the spirit and scope of the invention.
Example 1
Experimental conditions for nano field effect transistor
Devices are fabricated with graphene as the carrier channel of a two-terminal NFET without a physical gate terminal.
The polymer is disposed on graphene, typically less than 0.5mm thick, and then separated from the catalytic substrate on which the graphene is grown. A flexible polymer platform for a sensing system is used for a graded graphene polymer composite and two metal electrical contacts. The graphene polymer composite is bonded to a flexible polymer platform. A solution of the desired linker molecules is deposited on the graphene polymer complex for incubation. Removing the excess linking group molecule solution from the graphene polymer composite material; and two metal electrical contacts are deposited on two edges of the graphene polymer composite.
The graphene polymer composite is then placed on a polymer substrate, such as polytetrafluoroethylene, polyimide, etc., and then heated at 80-150 degrees celsius for 1-10 minutes to remove any impurities.
The GFET sensor is then ready for use. In some cases, receptors for a particular analyte are deposited on the graphene layer.
A sensor system for analyte sensing by sweat, wherein the sensor comprises:
a flexible polymer platform made of (polyimide);
the graphene polymer composite is bound to a flexible polymer platform;
source and drain electrodes in a sensor configuration located on opposite edges of the graphene polymer composite layer are also bonded to the flexible polymer platform;
each of the source and drain electrodes is composed of a conductive metal;
the graphene polymer composite layer is functionalized with a linker molecule for desired analyte biosensing between the two electrodes; and
the sensor system was analyzed in close proximity to the original sweat source.
A method of determining analyte concentration by sweat comprising the steps of:
applying a constant bias voltage to the functionalized graphene polymer composite sensor with the conductive channel;
measuring a first source-drain voltage across the sensor;
exposing the conductive pathway to the original sweat by placing the conductive pathway close to the source of sweat;
binding of the analyte to the linker molecule by releasing electrons into the channel through the linker, resulting in a change in the potential on the channel;
measuring a second source-drain voltage across the sensor;
the concentration of the analyte is determined based on a small change between the first source-drain voltage and the second source-drain voltage.
During analysis, a fixed current or voltage is passed through the sensor. The electrical response of the GFET sensor for analytes in polar solution was recorded using the analyte in Deionized (DI) water as a negative control. The DI water response on the functionalized GFET was also measured. Analytes include NaCl, D-glucose and lactate.
Example 2
Analysis of NaCl samples
In these examples, a fixed current or voltage is passed through the GFET. The electrical response of the GFET sensor was recorded as follows: naCl concentration in DI water, or DI water response on functionalized GFET.
Selectivity is: the response of various NaCl concentrations in DI water was measured on a GFET to investigate the sensitivity of the sensor to NaCl. Solutions with varying concentrations of NaCl were prepared at 0 to 1g/L in DI water. The test started with the introduction of 2ul of the lowest concentration on the GFET, followed by the next higher concentration after 3 minutes, and so on; for example, in the example shown in FIG. 6, the ratio was changed from 0.05g/L to 0.1g/L. This continues until all concentrations are introduced into the GFET.
Fig. 6 shows that GFET does not respond significantly to DI water alone, but has a linear response to increasing NaCl concentration in DI water. The increased concentration changes the voltage on the channel, showing high selectivity to NaCl in DI water as a control.
Sensitivity of the probe: the response of various NaCl concentrations in DI water was also measured on a GFET to investigate the sensitivity range of the sensor to NaCl. Solutions with exponentially increasing NaCl concentrations were prepared at 0.1ng/dL to 10mg/dL in DI water. The test started with the introduction of 2ul of the lowest concentration on the GFET, followed by the next higher concentration after 3 minutes, and so on. Here, the concentration increases logarithmically, e.g., from 0.1ng/dl to lng/dl, then 10ng/dl, then 0.1ug/dl, and so on. This continues until all concentrations are introduced into the GFET.
Fig. 7 shows that GFET did not respond significantly to DI water alone, but started responding exponentially from the lowest to the highest concentration of NaCl in DI water. The increase in concentration changes the voltage on the channel, showing a high sensitivity to NaCl in DI water at about 250 femtograms/liter as a control.
Chloride response in sweat: the chloride concentration in human sweat is measured with a human subject. The test requires the subject to perform a physical activity, such as running, and not to take water to moisturize.
GFET is worn by human subjects on the forearm and lower back (eccrine sweat glands). The electrical response due to chloride concentration in sweat is continuously transmitted and recorded (every 500 milliseconds) while the subject is engaged in intense physical activity (e.g., running). The observed change in chloride concentration in sweat is represented by a small change in voltage, as shown in fig. 8.
Figure 8 shows the real-time concentration of sweat osmolality of two human subjects using PFGFET attached to skin. Osmolality in sweat is directly related to the physical performance of the individual. Object 1 is a sprint and object 2 is a jogger. The sprint runner (object 1) runs the same distance at a faster speed (run 1) than the joggers (object 2 and run 2). The more intense the physical activity of the subject is observed, the higher the body weight osmolality measured. Peak body weight osmolality was observed during the most intense physical activity. A decrease in body weight osmolality during intense physical activity is also observed. This is caused in the event that the subject ingests too much water without sufficient supplementation of salt. In the data, when the slope of the curve goes towards 0, which indicates hyponatremia during which the body attempts to retain as much salt as possible (to maintain ionic balance), so the overall osmolarity changes very slowly.
The following novel results and/or features are observed.
High selectivity: GFET (NFET) regulated by PFGT produces a highly selective response to NaCl concentration in different control fluids: (>97%)。
High sensitivity: GFET functionalized with PBA has a high sensitivity to NaCl with a limit of detection (LOD) of 250 femtograms/liter. GFET sensors have a high signal-to-noise ratio, have high selectivity, and, due to the high surface area available for bonding, there is a higher bond between the surface and the molecule. All these factors act as great differences, making GFETs highly sensitive.
Gate modulation by polar molecules: in polar fluids (e.g., water, salt, etc.), polar molecules (e.g., ions, etc.) are observed to form a Polar Fluid Gate Terminal (PFGT) on the NFET. Polar molecules near the surface of the graphene induce a dielectric effect, thereby generating a charge transfer channel. The gating strength of PFGT depends on both the charge and the concentration of polar molecules in the fluid. This third Polar Fluid Gate Terminal (PFGT) modulates the electrical response of the NaCl concentration in the polar fluid.
Continuous monitoring: the concentration of ions in the fluid is continuously measured due to the modulation of the NFET channel current from the gate terminal of the induced polar fluid. Once the ionic solution is removed from the surface of the NFET, the electrical response of the polar fluid-gated NFET returns to the bare or initial value.
Induced motion of polarized fluid on NFET surface: it was observed that the polar fluid (e.g., naCl in DI water) would attempt to immediately repel or lift off the NFET surface due to the increased hydrophobicity between the NFET surface and the polar fluid. The higher the concentration of polar molecules (e.g., naCl) in the fluid, the greater the strength of the PFGT and thus the greater the repulsive effect. This repulsion effect, combined with the modulation of the electrical response induced by PFGT by NaCl molecules on NFETs, allows for highly sensitive, selective and continuous monitoring of the electrolyte system.
Real-time continuous chloride monitoring in human sweat: for example, human subjects wear GFET on the forearm and lower back (eccrine sweat glands). Sweat is diluted and ultrafiltered blood. The electrical response due to chloride concentration in sweat is continuously transmitted and recorded (every 500 milliseconds) while the subject is performing a) intense physical activity (exercise) b) no intense physical activity (such as sitting at a desk and eating). The background ion concentration in sweat (mainly NaCl) was observed to form PFGT on both end GFET devices. From Cl-The ion-induced change in the gating strength of PFGT induced on GFET allows continuous non-invasive monitoring of Cl ion molecules in human sweat. Sweat was observed to be a very good polar fluid, and chloride concentration could be measured continuously, as it was very dilute and ultrafiltered.
Example 3
Analysis of D-glucose samples
In these examples, a fixed current or voltage is passed through the GFET.
The electrical response of the GFET/PBA sensor is recorded as follows:
d-glucose concentration in DI Water
D-glucose concentration in Artificial sweat (DI + NaCl + lactic acid)
D-glucose concentration in DI water on non-functionalized GFET
Lactose concentration in DI water on functionalized devices (control 1)
Artificial sweat concentration on functionalized devices (control 2)
DI Water response on functionalized GFET
Human sweat glucose measurement: real-time continuous monitoring of glucose concentration in human sweat was performed using wearable GFET/PBA sensors. Correlating real-time continuous sweat glucose response to blood glucose measurement using a commercially available blood glucose meter
Functionalization: for example, graphene FETs are functionalized with linker molecules (locks) that specifically bind glucose molecules in the fluid. For example, GFET is functionalized with pyreneboronic acid (PBA). Pyreneboronic acid was bonded to the graphene surface using pi-pi bonding. PBA forms a reversible boron-anion complex with D-glucose. The preparation method comprises the following steps:
the polymer is placed on graphene, typically less than 0.5mm thick, and then separated from the catalytic substrate on which the graphene is grown.
The graphene polymer composite is then placed on a polymer substrate, such as polytetrafluoroethylene, polyimide, etc., and heated at 80-150 degrees celsius for 1-10 minutes to remove any impurities.
The graphene polymer was then introduced into the PBA solution for 5-20 minutes to functionalize at room temperature.
After the functionalization step, the sensor is ready for use.
The response of various D-glucose concentrations in DI water was measured on a GFET to investigate the sensitivity of the functionalized sensor to D-glucose.
Solutions were prepared with different concentrations of D-glucose (0.1 to 100mg/dL in DI water) and different concentrations of lactose were prepared in DI water. The test started with the introduction of 5ul of the lowest concentration on the GFET, followed by the next highest concentration after 3 minutes, and so on. This continues until all concentrations are introduced into the GFET.
Fig. 9 shows that GFET did not respond significantly to DI water or lactose solution, but exponentially to increased D-glucose concentration in DI water. The increased concentration changes the voltage on the channel, showing high selectivity to D-glucose for DI water as a control.
Glucose response in NaCl vs. DI Water: the response of various D-glucose concentrations in DI water and NaCl solution was measured on a GFET to study the sensitivity of the functionalized sensor to D-glucose in DI water and D-glucose in NaCl and to understand the effect of the NaCl solution.
Solutions with different concentrations of D-glucose from 0.1 to 100mg/dL were prepared in DI water and NaCl, respectively. The test started with the introduction of the lowest concentration of 5ul on the GFET, followed by the next higher concentration after 3 minutes, and so on. Here, the concentration increases logarithmically. This continues until all concentrations are introduced into the GFET.
FIG. 10 shows that the D-glucose response in NaCl is more amplified than in DI water. Providing a polar solution of PFGT on the GFET amplifies the electrical response on the channel, thereby increasing sensitivity and providing reversibility.
Selective measurement of glucose response in NaCl solutions: the response of various D-glucose concentrations in NaCl was measured on a GFET to investigate the sensitivity of the functionalized sensor to D-glucose.
Solutions were prepared with varying concentrations of D-glucose (0.1 to 100 mg/dL) in NaCl solution, and varying concentrations of NaCl in DI water. The test started with the introduction of the lowest concentration of 5ul on the GFET, followed by the next higher concentration after 3 minutes, and so on. Here, the concentration increases logarithmically. This continues until all concentrations are introduced into the GFET.
Fig. 11 shows that GFET did not respond significantly to NaCl-only solutions, whereas the solutions with increased NaCl concentration presented a linear response to the solutions with increased D-glucose concentration in the fixed NaCl concentration versus the solutions with increased NaCl concentration. The increase in concentration changes the voltage on the channel, thereby exhibiting high selectivity for D-glucose. GFET (NFET) functionalized with PBA produced a highly selective response (> 95%) to glucose concentration.
Fig. 11 gives the idea that the functionalized glucose sensor is not sensitive to NaCl (because the orange curve is rather flat), whereas the glucose curve increases with increasing concentration of glucose present in the NaCl solution.
Sensitivity measurement of D-glucose response in DI Water: the response of various D-glucose concentrations in the DI was measured on a GFET to investigate the sensitivity range of the functionalized sensor to D-glucose.
Solutions were prepared with exponentially increasing glucose concentrations (250 ng/l to 100 ng/l in DI water). The test started with 3 rounds of 5ul DI water introduction every 3 minutes, followed by a minimum concentration of 5ul on the GFET, followed by the next higher concentration after 3 minutes, and so on. Here, the concentration increases logarithmically; e.g., from 0.25pg/l, then 2.5pg/l, and so on. This continues until all concentrations are introduced into the GFET.
Fig. 12 shows that the GFET exhibited no significant response to DI water alone, but exhibited a linear response starting from the lowest concentration to the highest concentration, with the current in the channel changing as the concentration increased, thereby exhibiting about 250 femtograms/liter (i.e., 1.38 e) for D-glucose-12mmol/l) of the sample.
Step of functionalization: shown in fig. 13 is the current response of the graphene sensor before functionalization, after functionalization and after introduction of glucose on the sensor. This is useful for understanding each stage of the GFET manufacturing step and how the current response of the GFET changes after each stage. For example, as shown in fig. 13, the current response increases after functionalization (orange) compared to before functionalization (blue) because the linker molecules are bound by pi-pi bonds and the total charge on the graphene surface increases. The linker molecule, by using these charge clouds, attracts and binds the glucose molecule, thereby reducing the current on the GFET compared to its previous state.
D-glucose response in sweat and blood: glucose concentration in human sweat is measured with a human subject. The test requires the subject to perform physical activity, such as running, using a blood glucose meter every few minutes and to take a blood sample to measure blood glucose. GFET is worn by human subject on forearmAnd on the lower back (eccrine sweat glands). The electrical response due to the D-glucose concentration in sweat is continuously transmitted and recorded (every 500 milliseconds) while the subject is engaged in intense physical activity (e.g., running).
In this particular case, the physical activity is eating. As the subject begins to sit, his glucose will begin to rise, as can be seen from sweat and blood glucose. After the person finishes eating, the glucose level will begin to drop and stabilize.
In the case of running, when a person begins running, the body uses glucose and breaks it down to gain exercise energy. Therefore, you will see a decrease in glucose. However, after a period of time, your body insulin starts to work and the overall blood glucose level will start to rise again.
Fig. 14 shows the change in D-glucose concentration in sweat, represented by a small change in voltage.
The blood glucose data in fig. 15 is also plotted against time throughout the exercise period. The sweat glucose measurement is correlated to the blood glucose measurement. Here, sweat glucose values for corresponding blood glucose values are plotted against blood (blood versus sweat) to obtain a correlation R2It provides an idea of how well sweat glucose matches blood glucose.
Fig. 16 also shows the measurement correlation between blood glucose and sweat glucose. Here, 3 different sensors are used for the same person at the same time. Over 150 sweat curves and their blood glucose were collected from 10 human subjects for correlation throughout the study. The subject performs physical activity (exercise, running, etc.) or does not perform physical activity (sitting on a table, etc.). For these 150 curves, the calculated correlation between sweat and blood is R2=84%, also shown in the figure
The following novel results and/or features were observed.
High selectivity: GFET (NFET) functionalized with PBA produces a highly selective response to glucose concentration in different control fluids: (>95%)。
High sensitivity: GFET functionalized with PBA exhibits high sensitivity to D-glucose with a limit of detection (LOD) of 250 femtograms/liter, i.e., 1.38e-12mmol/l. The LOD of the existing glucometer is between 0.3 and 1.1 mmol/l. GFET functionalized with PBA is about 1010 times more sensitive than existing standard glucose measurement devices. GFET sensors have a high signal-to-noise ratio, have high selectivity, and, due to the high surface area for bonding, there is a higher bond between the surface and the receptor molecule. All these factors play a great differential role in making GFETs highly sensitive.
Gate modulation by polar molecules: in polar fluids (e.g., water, salt, etc.), polar molecules (e.g., ions) are observed to form a Polar Fluid Gate Terminal (PFGT) on the NFET. Polar molecules near the surface of graphene induce a dielectric effect, thereby creating a charge transfer channel. The gating strength of PFGT depends on the charge and concentration of polar molecules in the fluid. This third Polar Fluid Gate Terminal (PFGT) regulates the electrical response from the glucose concentration in the polar fluid.
Continuous blood glucose monitoring: charge modulation greatly enhances the reversibility of PBA-glucose bonds on graphene surfaces due to the polar fluid gate terminal on NFETs formed in a polar fluid. The higher the concentration of polar molecules (e.g., ions, etc.) in the polar fluid, the more reversible the PBA-D-glucose linkages are observed. Once the concentration of glucose bound on the sensor is higher than the glucose concentration in sweat, the glucose molecules are detached from the PBA due to their Gibbs (Gibbs) free energy, observing a reversible nature, which is clearly seen in the electrical response recorded in fig. 14, as the concentration of glucose drops instantaneously. This allows for reusable real-time continuous monitoring of D-glucose molecules in polar fluids.
Reusability of glucose sensors due to movement of polar fluids on the sensor surface: it was observed that the movement of a polar fluid (e.g., glucose in a salt) on the NFET enhanced the removal of bound glucose molecules from the linker molecules. As an example, when removing from the graphene surface in a GFETThe electrical response of GFET returned to the naked value with glucose solution.
Induced motion of polarized fluid on NFET surface: it was observed that the polar fluid (e.g., glucose in salt) would attempt to repel or lift off the NFET surface immediately due to the increased hydrophobicity between the NFET surface and the polar fluid. The higher the concentration of polar molecules in the fluid, the greater the strength of the PFGT and therefore the greater the repulsive effect. This repulsive effect, combined with the removal of bound glucose molecules (described above in section e) and the modulation of the electrical response due to PFGT on NFETs, allows for highly sensitive, selective and continuous monitoring of the glucose system.
Real-time continuous blood glucose monitoring in human sweat: GFET functionalized with PBA was worn by human subjects on the forearms and lower back (eccrine sweat glands). Sweat is diluted and ultrafiltered blood. The electrical response due to the glucose concentration in sweat is continuously transmitted and recorded (every 500 milliseconds) while the subject is performing: a) Intense physical activity (exercise) and b) no intense physical activity (such as sitting at a desk for eating). Sweat glucose response is related to blood glucose readings taken every few minutes using a blood glucose meter over the length of the activity (typically 20 minutes to over 6 hours). The background ion concentration in sweat (mainly NaCl) was observed to form PFGT on both end GFET/PBA devices. The enhanced reversibility between PFGT, PBA and D-glucose bonds on GFET allows continuous non-invasive monitoring of glucose molecules in human sweat. Calculate 84% (R) between blood glucose and sweat glucose measurements2) The correlation of (c). Correlations of over 150 sweat glucose responses collected from 10 human subjects under various physical activity conditions were calculated. Sweat is observed to be a very good polar fluid, allowing continuous glucose measurement because it is very dilute and ultrafiltered.
Example 4
Analysis of lactic acid samples
In these examples, a fixed current or voltage is passed through the GFET.
Functionalization: linker molecule (lock) functionalization for graphene FETsWhich specifically binds to lactic acid molecules in the fluid. For example, GFET was functionalized with lactate oxidase (LOx) to the graphene surface using intermediate pyrene-NHS ligation chemistry.
The polymer is placed on graphene, typically less than 0.5mm thick, and then separated from the catalytic substrate on which the graphene is grown.
The graphene polymer composite is then placed on a polymer substrate, such as polytetrafluoroethylene, polyimide, etc., and heated at 80-150 ℃ for 1-10 minutes to remove any impurities.
The graphene polymer was then introduced into the pyrene-NHS solution for 5-20 minutes to functionalize at room temperature.
The graphene polymer was then introduced into the LOx solution and allowed to bind for 520 minutes at room temperature.
After the functionalization step, the sensor is ready for use.
The electrical response of the GFET/LOx sensor is recorded as follows:
lactic acid concentration in DI Water
Lactic acid concentration in Artificial sweat (DI + NaCl + glucose)
Lactic acid concentration in NaCl on non-functionalized GFET
Lactic acid concentration in NaCl on functionalized GFET
Artificial sweat concentration on functionalized devices (control 2)
DI Water response on functionalized GFET
Selective measurement of lactate response in DI water: the response of various lactate concentrations in the DI was measured on a GFET to investigate the sensitivity of the functionalized sensor to lactate. Solutions with varying concentrations of 0-25mM lactic acid were prepared in DI water. The test started with the introduction of 2ul of the lowest concentration on the GFET, followed by the introduction of the next highest concentration after 3 minutes, and so on. This continues until all concentrations are introduced into the GFET.
Fig. 17 demonstrates that GFET does not respond significantly to DI water alone and that the polynomial response to the increase in lactic acid concentration in DI water, which changes the voltage across the channel, demonstrates high selectivity to lactic acid in DI water, using DI water as a control.
Selective measurement of lactate response in various solutions: the response of various concentrations of lactate in various solutions was measured on a GFET to study the sensitivity of functionalized sensors to lactate and the response to non-functionalized sensors. Solutions with different concentrations of lactic acid of 0-25mM were prepared in NaCl and NaCl-glucose. The test started with the introduction of 2ul of the lowest concentration on the GFET, followed by the introduction of the next highest concentration after 3 minutes, and so on. This continues until all concentrations are introduced into the GFET, separately for each solution.
Fig. 18 shows that GFET did not respond significantly to NaCl only or NaCl-glucose controls, while exhibiting a polynomial response to increasing lactate concentrations in NaCl and NaCl-glucose solutions. The increase in concentration changes the voltage across the channel, thereby exhibiting high selectivity to lactic acid. The non-functionalized sensor did not respond significantly to the lactate NaCl solution, further emphasizing the selectivity and sensitivity of the sensor to lactate.
Lactic acid response in NaCl vs. DI Water: the response of various lactate concentrations in DI water and NaCl solution was measured on a GFET to investigate the sensitivity of the functionalized sensor to lactate in DI water and lactate in NaCl, and to understand the effect of NaCl solution. Solutions of lactic acid (0.1 to 100 mg/dL) were prepared at different concentrations in DI water and NaCl, respectively. The test started with the introduction of 2ul of the lowest concentration on the GFET, followed by the next higher concentration after 3 minutes, and so on. This continues until all concentrations are introduced into the GFET.
Figure 19 shows that the lactate response in NaCl is less amplified than the lactate response in DI water.
Lactic acid functionalization step visualized by GFET manufacturing: the current response of the graphene sensor before functionalization, after functionalization and after introduction of lactic acid into the sensor is shown in fig. 20. This is useful for understanding each stage of the GFET manufacturing step and how the current response of the GFET changes after each stage. For example, fig. 20 shows that the current response is reduced after functionalization (orange) compared to before functionalization (blue). In comparison with the previous state thereof,the linker molecule attracts and binds to the lactic acid molecule, thereby reducing the current on the GFET.
The following novel results and/or features are observed.
High selectivity: GFET (NFET) functionalized with LOx produces a highly selective response to lactate concentration in different control fluids: (>94%)。
High sensitivity: GFET functionalized with pyrene NHS has high sensitivity to lactic acid with a limit of detection (LOD) of 250 femtograms/liter; i.e. 2.78e-12mmol/l. The LOD of the existing lactic acid meter is between 0.001 and 10 mmol/l. GFET functionalized with pyrene NHS is about 108 times more sensitive than existing standard lactate measurement devices. GFET sensors have a high signal-to-noise ratio, have high selectivity, and, due to the high surface area for bonding, there is a higher bond between the surface and the receptor molecule. All these factors play a great differential role in making GFETs highly sensitive.
Gate modulation by polar molecules: in polar fluids (e.g., water, salt, etc.), polar molecules (e.g., ions) are observed to form a Polar Fluid Gate Terminal (PFGT) on the NFET. Polar molecules near the surface of the graphene induce a dielectric effect, thereby generating a charge transfer channel. The gating strength of PFGT depends on the charge and concentration of polar molecules in the fluid. This third Polar Fluid Gate Terminal (PFGT) modulates the electrical response from the concentration of lactic acid in the polar fluid.
Induced motion of polarized fluid on NFET surface: it was observed that the polar fluid (such as lactic acid in artificial sweat) would attempt to immediately repel or break away from the NFET surface due to the increased hydrophobicity between the NFET surface and the polar fluid. The higher the concentration of polar molecules in the fluid, the greater the strength of the PFGT and therefore the greater the repulsive effect. This repulsive effect, combined with the modulation of the electrical response caused by PFGT on the NFET, allows for highly sensitive, selective and continuous monitoring of the lactic acid system.
Example 5
Other analysis
Sweat salt concentration correlation: FIG. 21 shows a sweat sensor pair for corresponding sweatResponse to sodium concentration.
Increasing concentrations of NaCl (0.1 mg/dl to 100 mg/dl) were added to the graphene sensor every 3 minutes. At the start of the test 2ul of the lowest concentration (e.g. 0.1 mg/dl) was added dropwise, followed by the next higher concentration (e.g. 0.2 mg/dl) and so on at 3 minute intervals. The corresponding small change in voltage is measured. This procedure was repeated for 10 different sensors, with a maximum error of 15% being observed. This serves as a model for the correlation between sodium sweat and the corresponding voltage change.
Sweat glucose concentration correlation: fig. 22 shows the response of a sweat sensor to the corresponding sweat glucose concentration.
Increasing concentrations of glucose (0.1 mg/dl to 100 mg/dl) were added to the graphene sensor every 3 minutes. The test starts with the addition of 5ul of the lowest concentration (e.g., 0.1 mg/dl), followed by the next higher concentration (e.g., 0.2 mg/dl), and so on, at 3 minute intervals, and the corresponding small change in voltage is measured. This procedure was repeated for 10 different sensors, with a maximum error of 5% being observed. This serves as a model for the correlation between sweat glucose and the corresponding voltage change.
Transconductance curve: fig. 23 shows the transconductance curves of a PFGT device.
NaCl solutions at concentrations ranging from 0.1ng/dl to 1mg/dl were added dropwise to the sensor every 3 minutes. The test started with the addition of 2ul of the lowest concentration (e.g., 0.1 ng/dl), followed by the decrease of the next higher concentration (1 ng/dl), and so on, at 3 minute intervals.
When a polar fluid is introduced, a debye layer is formed on the graphene sensor and a gating effect is observed, both the debye length and the gating effect being a function of the polar molecule concentration. For the initial concentration of NaCl solution, DI was more dominant, thereby generating more holes and we seen a voltage drop. However, after a few drops, as the NaCl concentration in the solution increases, it becomes more dominant and more electrons are generated near the debye layer, exhibiting an increase in voltage.
This demonstrates the transconductance characteristics of graphene sensors gated with polar fluids.
The various methods and techniques described above provide a number of ways to implement the present invention. Of course, it is to be understood that all of the objects or advantages described may be achieved in accordance with any particular embodiment described herein. Thus, for example, those skilled in the art will recognize that the methods may be performed in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objectives or advantages as may be taught or suggested herein. Various advantageous and disadvantageous alternatives are mentioned herein. It will be appreciated that some preferred embodiments specifically include one, another or several advantageous features, while other preferred embodiments specifically exclude one, another or several disadvantageous features, while other preferred embodiments specifically mitigate one existing disadvantageous feature, another or several advantageous features by including one.
Furthermore, the skilled person will recognise the applicability of various features from different embodiments. Similarly, various elements, features and steps discussed above, as well as other known equivalents for each such element, feature or step, can be mixed and matched by one of ordinary skill in this art to perform methods in accordance with principles described herein. Among the various elements, features and steps, some will be specifically included and others will be specifically excluded in different embodiments.
Although the present invention has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the embodiments of the present invention extend beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and modifications and equivalents thereof.
Many variations and alternative elements have been disclosed in the embodiments of the invention. Further modifications and alternative elements will be apparent to those skilled in the art.
In some embodiments, numbers expressing quantities of ingredients, properties such as molecular weight, response conditions, and so forth, used to describe and claim certain embodiments of the invention are to be understood as being modified in certain instances by the term "about". Accordingly, in some embodiments, the numerical parameters set forth in the written description and attached claims are approximations that may vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific embodiments are reported as precisely as possible. Numerical values presented in some embodiments of the invention may include certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
In some embodiments, the terms "a" and "an" and "the" and similar references used in the context of describing particular embodiments of the invention (especially in the context of certain of the following claims) may be construed to cover both the singular and the plural. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., "such as") provided with respect to certain embodiments herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member may make any combination of references and requirements, alone or with other members of the group or other elements found herein. One or more group members may be included in or deleted from the group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is considered herein to include the modified group, thereby enabling the written description of all markush groups used in the appended claims.
Preferred embodiments of the present invention are described herein. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. It is contemplated that skilled artisans may employ such variations as appropriate, and the invention may be practiced otherwise than as specifically described herein. Accordingly, many embodiments of the invention include all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
In addition, throughout the specification, many references have been made to patents and printed publications. Each of the references and printed publications cited above is incorporated by reference herein in its entirety.
Finally, it is to be understood that the embodiments of the invention disclosed herein are illustrative of the principles of the invention. Other modifications that may be employed may be within the scope of the invention. Thus, by way of example, and not limitation, alternative configurations of the present invention may be utilized in accordance with the teachings herein. Thus, embodiments of the invention are not limited to those precisely as shown and described.
Claims (21)
1. A field effect transistor, comprising:
at least one drain electrode;
at least one source electrode;
a substrate; and
a nanoscale material layer disposed on the substrate, the nanoscale material layer serving as an electrically conductive and chemically sensitive channel extending between and electrically connecting the source electrode and the drain electrode,
wherein the field effect transistor is configured to: the field effect transistor operates as an active device when a polar fluid is introduced into the channel from the outside, wherein the polar fluid includes a target analyte, and wherein the polar fluid induces a gate voltage, and the gate voltage is related to the concentration of the target analyte, and
wherein the nanoscale material comprises graphene, CNT, moS2Boron nitride, a metal disulfide, a phosphorus alkene, a fullerene, or any combination thereof.
2. The field effect transistor of claim 1, wherein the polar fluid is introduced into the channel from the outside as a droplet.
3. The field effect transistor of claim 1, wherein the polar fluid is introduced into the channel from the outside when the field effect transistor is in contact with and/or immersed in a volume of the polar fluid.
4. The field effect transistor of claim 1, wherein the active device is configured to function as a sensing device.
5. The field effect transistor of claim 4, wherein the active device is configured for biosensing.
6. The field effect transistor of claim 1, wherein the field effect transistor does not include or require a permanent physical gate terminal to be formed on the substrate.
7. The field effect transistor of claim 1, wherein the polar fluid and the channel collectively function as a gate terminal.
8. The field effect transistor of claim 7, wherein the gate terminal is transient and is active only when the polar fluid is introduced into the channel from the outside.
9. The field effect transistor of claim 1, wherein the field effect transistor does not operate as the active device when the polar fluid is removed from the channel.
10. The field effect transistor of claim 1, wherein the channel is conductive and chemically and/or biologically sensitive.
11. The field effect transistor of claim 1, wherein the layer of nanoscale material is epitaxially grown and transferred onto the substrate using a wet or dry deposition process.
12. The field effect transistor of claim 1, wherein the polar fluid comprises a solution or a gas with polar molecules.
13. The field effect transistor of claim 1, wherein the polar fluid comprises sweat, breath, saliva, cerumen, urine, semen, plasma, biological fluid, chemical fluid, air sample, gas sample, or a combination thereof.
14. The field effect transistor of claim 1, wherein the polar fluid comprises one or more target analytes including electrolytes, glucose, lactate, IL6, cytokines, HER2, cortisol, ZAG, cholesterol, vitamins, proteins, drug molecules, metabolites, polypeptides, amino acids, DNA, RNA, aptamers, enzymes, biomolecules, chemical molecules, synthetic molecules, or combinations thereof.
15. The field effect transistor of claim 1, further comprising:
a receptor layer coupled to the nanoscale material layer, wherein the receptor layer comprises one or more receptors targeted to the one or more target analytes.
16. The field effect transistor of claim 15, wherein the one or more acceptors comprise Pyrene Boronic Acid (PBA), pyrene N-hydroxysuccinimide ester (pyrene-NHS), organic chemicals, aromatic molecules, cyclic molecules, enzymes, proteins, antibodies, viruses, single stranded DNA (ssDNA), aptamers, inorganic materials, synthetic molecules, or biomolecules.
17. The field effect transistor of claim 1, further comprising:
a back polymer layer coupled to the nanoscale material layer, wherein the back polymer layer is configured to provide support for additional mechanical, electrical, chemical, biological functions, or a combination thereof.
18. The field effect transistor of claim 17, wherein the back polymer layer comprises: carbon polymers, biopolymers, PMMA, PDMS, flexible glass, nanoscale materials, silica gel, silicone, inks, printed polymers, or any combination thereof.
19. The field effect transistor of claim 1, wherein the substrate comprises polyimide, flexible Printed Circuit (FPC), polyamide, polyurethane, PET, PDMS, PMMA, silica, silicon, glass, alumina, sapphire, germanium, gallium arsenide, indium phosphide, alloys of silicon and germanium, fabric, textile, wire, paper, cellulose substrate, or any combination thereof.
20. The field effect transistor of claim 1, wherein the substrate is made of an electrically insulating material.
21. A biosensing system comprising the field effect transistor of claim 1, wherein the biosensing system or element thereof is configured to be worn by a subject, and the field effect transistor is configured to: detecting one or more analytes in the polar fluid when the polar fluid is introduced into the channel from outside the body of the subject.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211200989.1A CN115753941A (en) | 2016-06-30 | 2017-06-30 | Polar fluid gated field effect device |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662356729P | 2016-06-30 | 2016-06-30 | |
US201662356742P | 2016-06-30 | 2016-06-30 | |
US62/356,742 | 2016-06-30 | ||
US62/356,729 | 2016-06-30 | ||
PCT/IB2017/001003 WO2017216641A2 (en) | 2016-06-18 | 2017-06-30 | Polar fluid gated field effect devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211200989.1A Division CN115753941A (en) | 2016-06-30 | 2017-06-30 | Polar fluid gated field effect device |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109642888A CN109642888A (en) | 2019-04-16 |
CN109642888B true CN109642888B (en) | 2022-11-01 |
Family
ID=65762403
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211200989.1A Pending CN115753941A (en) | 2016-06-30 | 2017-06-30 | Polar fluid gated field effect device |
CN201780050922.5A Active CN109642888B (en) | 2016-06-30 | 2017-06-30 | Polar fluid gated field effect device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211200989.1A Pending CN115753941A (en) | 2016-06-30 | 2017-06-30 | Polar fluid gated field effect device |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3472607A4 (en) |
JP (3) | JP7129405B2 (en) |
KR (2) | KR102653287B1 (en) |
CN (2) | CN115753941A (en) |
WO (1) | WO2017216641A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108181367B (en) * | 2017-12-26 | 2020-07-21 | 湖北大学 | A kind of DNA sensor based on graphene transistor and its preparation method and application in DNA detection |
WO2019183279A1 (en) | 2018-03-20 | 2019-09-26 | Graphwear Technologies Inc. | Replaceable sensor systems and methods |
JP6876661B2 (en) * | 2018-09-13 | 2021-05-26 | 株式会社東芝 | Organic probe and molecule detector |
CN112345614B (en) * | 2019-08-08 | 2023-07-21 | 中国科学院微电子研究所 | Detector based on gallium nitride-based enhancement device and manufacturing method thereof |
EP3819260A1 (en) * | 2019-11-07 | 2021-05-12 | Infineon Technologies AG | A composite material, a chemoresistive gas sensor, a chemoresistive gas sensor system and a method for making and using same |
EP4124855A1 (en) | 2021-07-29 | 2023-02-01 | Consejo Superior De Investigaciones Científicas (CSIC) | Graphene biosensor for the detection of hepatitis c virus |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8716029B1 (en) * | 2010-09-21 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The United States | Carbon nanotube sensors employing synthetic multifunctional peptides for surface functionalization |
WO2015054663A3 (en) * | 2013-10-11 | 2015-10-29 | The Regents Of The University Of California | Biomolecular interaction detection devices and methods |
WO2015200758A2 (en) * | 2014-06-26 | 2015-12-30 | Tufts University | 3d graphene transistor |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4587539B2 (en) | 1999-09-13 | 2010-11-24 | アイメック | Apparatus for detecting analytes in samples based on organic materials |
JP4891550B2 (en) | 2005-02-10 | 2012-03-07 | 独立行政法人科学技術振興機構 | N-type transistor, n-type transistor sensor, and n-type transistor channel manufacturing method |
US8017938B2 (en) * | 2006-03-17 | 2011-09-13 | The United States Of America As Represented By The Department Of Health And Human Services | Apparatus for microarray binding sensors having biological probe materials using carbon nanotube transistors |
KR100773549B1 (en) * | 2006-04-03 | 2007-11-07 | 삼성전자주식회사 | How to detect biomolecules using same field effect transistor |
EP2069773A2 (en) | 2006-09-22 | 2009-06-17 | Koninklijke Philips Electronics N.V. | Semiconductor sensor device, diagnostic instrument comprising such a device and method of manufacturing such a device |
JP2008258594A (en) | 2007-03-09 | 2008-10-23 | Hokkaido Univ | Carbon nanotube field effect transistor manufacturing method and biosensor device |
CA2701447A1 (en) | 2007-10-01 | 2009-07-09 | University Of Southern California | Methods of using and constructing nanosensor platforms |
US8169006B2 (en) * | 2008-11-29 | 2012-05-01 | Electronics And Telecommunications Research Institute | Bio-sensor chip for detecting target material |
US8853667B2 (en) | 2011-12-06 | 2014-10-07 | Jain Faquir C | Quantum dot gate FETs and circuits configured as biosensors and gene sequencers |
US8896032B2 (en) | 2013-01-23 | 2014-11-25 | International Business Machines Corporation | Self-aligned biosensors with enhanced sensitivity |
US9765395B2 (en) * | 2014-04-28 | 2017-09-19 | Nanomedical Diagnostics, Inc. | System and method for DNA sequencing and blood chemistry analysis |
EP3235010A4 (en) * | 2014-12-18 | 2018-08-29 | Agilome, Inc. | Chemically-sensitive field effect transistor |
-
2017
- 2017-06-30 JP JP2019518162A patent/JP7129405B2/en active Active
- 2017-06-30 CN CN202211200989.1A patent/CN115753941A/en active Pending
- 2017-06-30 WO PCT/IB2017/001003 patent/WO2017216641A2/en unknown
- 2017-06-30 KR KR1020197001607A patent/KR102653287B1/en active Active
- 2017-06-30 CN CN201780050922.5A patent/CN109642888B/en active Active
- 2017-06-30 EP EP17812823.7A patent/EP3472607A4/en active Pending
- 2017-06-30 KR KR1020247010269A patent/KR20240045375A/en active Pending
-
2022
- 2022-07-01 JP JP2022107238A patent/JP7449333B2/en active Active
-
2024
- 2024-03-01 JP JP2024031345A patent/JP2024055954A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8716029B1 (en) * | 2010-09-21 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The United States | Carbon nanotube sensors employing synthetic multifunctional peptides for surface functionalization |
WO2015054663A3 (en) * | 2013-10-11 | 2015-10-29 | The Regents Of The University Of California | Biomolecular interaction detection devices and methods |
WO2015200758A2 (en) * | 2014-06-26 | 2015-12-30 | Tufts University | 3d graphene transistor |
Non-Patent Citations (1)
Title |
---|
Solution-Gated Graphene Field Effect Transistors Integrated in Microfluidic Systems and Used for Flow Velocity Detection;Xiang He et al.;《Nano Lett.》;20120210;第12卷;全文 * |
Also Published As
Publication number | Publication date |
---|---|
EP3472607A4 (en) | 2020-02-19 |
KR20190027828A (en) | 2019-03-15 |
JP7129405B2 (en) | 2022-09-01 |
CN109642888A (en) | 2019-04-16 |
CN115753941A (en) | 2023-03-07 |
KR20240045375A (en) | 2024-04-05 |
JP2019525200A (en) | 2019-09-05 |
JP7449333B2 (en) | 2024-03-13 |
EP3472607A2 (en) | 2019-04-24 |
JP2024055954A (en) | 2024-04-19 |
WO2017216641A3 (en) | 2018-02-15 |
KR102653287B1 (en) | 2024-03-29 |
JP2022121664A (en) | 2022-08-19 |
WO2017216641A2 (en) | 2017-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109642888B (en) | Polar fluid gated field effect device | |
Sheibani et al. | Extended gate field-effect-transistor for sensing cortisol stress hormone | |
Hao et al. | Graphene-based fully integrated portable nanosensing system for on-line detection of cytokine biomarkers in saliva | |
US20190257732A1 (en) | Polar fluid gated field effect devices | |
Liu et al. | Highly sensitive and wearable In2O3 nanoribbon transistor biosensors with integrated on-chip gate for glucose monitoring in body fluids | |
Park et al. | Ultrasensitive flexible graphene based field-effect transistor (FET)-type bioelectronic nose | |
Yan et al. | Solution‐gated graphene transistors for chemical and biological sensors | |
Reddy et al. | High-k dielectric Al 2 O 3 nanowire and nanoplate field effect sensors for improved pH sensing | |
Kehayias et al. | Kelvin probe microscopy and electronic transport measurements in reduced graphene oxide chemical sensors | |
Kwon et al. | Nanoscale FET-based transduction toward sensitive extended-gate biosensors | |
Fu et al. | Electrolyte-gated graphene ambipolar frequency multipliers for biochemical sensing | |
Kotlowski et al. | Electronic biosensing with flexible organic transistor devices | |
Wang et al. | High-stability pH sensing with a few-layer MoS2 field-effect transistor | |
Rollo et al. | High aspect ratio fin-ion sensitive field effect transistor: Compromises toward better electrochemical biosensing | |
Park et al. | Carbon nanotube-based ion-sensitive field-effect transistors with an on-chip reference electrode toward wearable sodium sensing | |
WO2015001286A1 (en) | Biosensor | |
Chen et al. | Chemiresistive and gravimetric dual-mode gas sensor toward target recognition and differentiation | |
Sultan et al. | Effect of Phosphate Buffered Saline Solutions on Top‐Down Fabricated ZnO Nanowire Field Effect Transistor | |
Pindoo et al. | Increased sensitivity of biosensors using evolutionary algorithm for bio-medical applications | |
US20220170920A1 (en) | Apparatus and method for measuring hormone concentration in biofluids | |
Lynall et al. | Nonlinear chemical sensitivity enhancement of nanowires in the ultralow concentration regime | |
Jin et al. | Ultrasensitive Graphene Field-Effect Biosensors Based on Ferroelectric Polarization of Lithium Niobate for Breast Cancer Marker Detection | |
Talukdar et al. | Sensitivity and reliability assessment of pocket doped NCFET based dielectrically modulated biosensor considering steric hindrance effects | |
Jang et al. | Fine Tuning of Electrical Characteristics of Inkjet Printed Graphene for Physical and Chemical Sensing | |
Laliberte | Graphene Transistor-Based Printable Electronics for Wearable Biosensing Applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |